Major Government Spending Bill Covers FDA, Research Issues
Multiple provisions crucial to FDA operations and authority, in addition to clinical research sponsors and pharmaceutical manufacturers, are included in the year-end, must-pass government...
Funding of Millions of Pounds Towards Genomics Research
The benefits of earlier detection and quicker access to treatments will be felt by cancer patients as well as newborns with curable but uncommon...
First Gene Treatment For Early Bladder Cancer Okayed By FDA
The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or without papillary tumours has...
Hemophilia Gene Therapy Now Backed By European Regulators
The agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy for haemophilia, a combo...
WHO Revises Treatment Recommendations For Drug-Resistant TB
The World Health Organization (WHO) has released its revised consolidated recommendations for treating drug-resistant tuberculosis (DR-TB), which include significant advancements in the treatment options...
By 2032, The Alzheimers Treatments Market Will Be $6.8 Bn
The global Alzheimer's therapeutics market is anticipated to develop at a compound annual growth rate (CAGR) of 9.3% and reach $6.8 billion by 2032, according...
New Zealand Health Agencies Aim To Improve Clinical Trials
Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...